The lack of ATM or reduction of its phosphorylated form shift the glucose-dependent energy metabolism to other substrates and cause reduction of OXPHOS and mitochondrial dysfunction, thus rendering cancer cells more sensitive to oncogene driver inhibitors and apoptotic stimuli. The gene discussed is ATM; the disease is cancer.